Market Overview The EMEA anorexiants market focuses on pharmaceutical solutions for obesity and metabolic disorders, with a strong emphasis on oral formulations due to ease of use and compliance. Europe dominates with advanced healthcare infrastructure and high disposable incomes, while the Middle East and Africa show emerging growth through urbanization and government health...